The head of a British business targeted relentlessly by animal rights extremists has called on the financial services industry to stop treating his company as “radioactive”.

Brian Cass, managing director of Huntingdon Life Sciences, urged banks, insurers, auditors and the financial markets to shrug off fears of intimidation and have the courage to work with his company and others involved in the development of medicines.